Alysha Kadva

Affiliations

Genentech, South San Francisco, CA, USA.

Publications (2)

Etrolizumab for maintenance therapy in patients with moderately to severely active ulcerative colitis (LAUREL): a randomised, placebo-controlled, double-blind, phase 3 study.

The lancet. Gastroenterology & hepatology

Avec: Severine Vermeire , Peter L Lakatos , Timothy Ritter , Stephen Hanauer , Brian Bressler , Reena Khanna , Kim Isaacs , Saumin Shah , Helen Tyrrell , Young S Oh , Swati Tole , Akiko Chai , Jennifer Pulley , Christopher Eden , Wenhui Zhang , Brian G Feagan , Auteur inconnu

Pharmacokinetics, Pharmacodynamics, and Safety of Etrolizumab in Children With Moderately to Severely Active Ulcerative Colitis or Crohn's Disease: Results from a Phase 1 Randomized Trial.

Inflammatory bowel diseases

Avec: Wenhui Zhang , Astrid Scalori , Franklin Fuh , Jacqueline McBride , Gaohong She , Jaroslaw Kierkus , Bartosz Korczowksi , Regan Li , Mariam Abouhossein , K T Park , Meina Tao Tang

Réseau de co-auteurs

Wenhui Zhang 2 collaborations

Severine Vermeire 1 collaboration

Peter L Lakatos 1 collaboration

Timothy Ritter 1 collaboration

Stephen Hanauer 1 collaboration

Brian Bressler 1 collaboration

Reena Khanna 1 collaboration

Kim Isaacs 1 collaboration

Saumin Shah 1 collaboration

Helen Tyrrell 1 collaboration

Young S Oh 1 collaboration

Swati Tole 1 collaboration

Akiko Chai 1 collaboration

Jennifer Pulley 1 collaboration

Christopher Eden 1 collaboration

Brian G Feagan 1 collaboration

None None 1 collaboration

Astrid Scalori 1 collaboration

Franklin Fuh 1 collaboration

Jacqueline McBride 1 collaboration

Gaohong She 1 collaboration

Jaroslaw Kierkus 1 collaboration

Bartosz Korczowksi 1 collaboration

Regan Li 1 collaboration

Mariam Abouhossein 1 collaboration

K T Park 1 collaboration

Meina Tao Tang 1 collaboration